Literature DB >> 16271954

The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population.

Ming-Juan Jin1, Kun Chen, Liang Song, Chun-Hong Fan, Qing Chen, Yi-Min Zhu, Xin-Yuan Ma, Kai-Yan Yao.   

Abstract

Growing evidence suggests that the Thr241Met (T241M) polymorphism in the homologous recombination repair gene XRCC3 may alter DNA repair capacity and subsequent susceptibility to carcinogens. In a few studies of colorectal cancer (CRC), however, the results have been discrepant. A population-based nested case-control study including 140 cases and 280 cancer-free controls was conducted to evaluate the effect of XRCC3 polymorphism, environmental exposure, and family history (FH) on the risk of CRC. The variant allele frequency was low among the ethnic Han Chinese, but we observed a significant difference between cases (6.07%) and controls (2.32%). The analytic results of the unconditional logistic regression model adjusted by age, sex, alcohol intake, cigarette smoking, and FH of cancer in first-degree relatives showed a significantly increased risk of CRC (adjusted odds ratio [OR] = 3.13, 95% confidence interval [CI]: 1.41-6.95, P = 0.005) as the T/M and M/M genotypes compared with the T/T genotype, which changed weakly in consideration of the subsite (adjusted OR = 4.80, 95%CI: 1.77-12.98, P = 0.002 in colon cancer, adjusted OR = 2.41, 95%CI: 0.93-6.25, P = 0.071 in rectal cancer, respectively). Combined with environmental factors such as alcohol intake and cigarette smoking, no significant interaction could be found. However, the results revealed a significant association between FH of cancer in first-degree relatives and the risk of CRC (adjusted OR = 2.24, 95%CI: 1.18-4.25, P = 0.014). These results also suggest that XRCC3 T241M polymorphism and FH of cancer may be risk factors for CRC, and the XRCC3 241Met allele may be an effective biomarker for genetic susceptibility to CRC. Larger studies are needed to confirm our findings and identify the underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271954     DOI: 10.1016/j.cancergencyto.2005.05.001

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  16 in total

1.  The Thr241Met polymorphism in the XRCC3 gene is associated with increased risk of cancer in Chinese mainland populations.

Authors:  Liang Du; Tianyuan Xiong; Qing He; Yayi Wang; Jiani Shen; Yuanling Peng; Qingyi Jia; Jiqiao Yang; Yonggang Zhang; Jin Huang
Journal:  Tumour Biol       Date:  2013-11-07

2.  No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.

Authors:  Yun-Hua Xu; Lin-Ping Gu; Ying-Jia Sun; Bai-Jun Cheng; Shun Lu
Journal:  Tumour Biol       Date:  2013-01-09

3.  Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies.

Authors:  Li Liu; Lin Miao; Guozhong Ji; Fulin Qiang; Zheng Liu; Zhining Fan
Journal:  Mol Biol Rep       Date:  2012-12-28       Impact factor: 2.316

4.  XRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis.

Authors:  Jinghua Fan; Yuhua Fan; Xiaoxiao Kang; Limin Zhao
Journal:  Oncol Lett       Date:  2015-03-16       Impact factor: 2.967

5.  Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population.

Authors:  Xin Tian; Ye Tian; Ping Ma; Chengguang Sui; Fandong Meng; Yan Li; Liye Fu; Tao Jiang; Yang Wang; Youhong Jiang
Journal:  Tumour Biol       Date:  2013-06-08

6.  TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Fang Fang; Long Yu; Yang Zhong; Lei Yao
Journal:  Med Oncol       Date:  2009-12-10       Impact factor: 3.064

7.  Polymorphisms in XPC provide prognostic information in acute myeloid leukemia.

Authors:  Peipei Xu; Baoan Chen; Jifeng Feng; Lu Cheng; Guohua Xia; Yufeng Li; Jun Qian; Jiahua Ding; Zuhong Lu
Journal:  Int J Hematol       Date:  2012-09-12       Impact factor: 2.490

8.  MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.

Authors:  Jee Hyun Park; Nung Soo Kim; Jae Yong Park; Yee Soo Chae; Jong Gwang Kim; Sang Kyun Sohn; Joon Ho Moon; Byung Woog Kang; Hun Mo Ryoo; Sung Hwa Bae; Gyu Seog Choi; Soo-Han Jun
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-21       Impact factor: 4.553

9.  Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk.

Authors:  ZhiZhen Wang; Wencheng Zhang
Journal:  Tumour Biol       Date:  2013-03-17

10.  Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.

Authors:  Kai Yuan; Meiling Huo; Yong Sun; Hongyan Wu; Hongqiang Chen; Yulong Wang; Rongzhan Fu
Journal:  Tumour Biol       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.